Global Prostate Cancer Diagnostics Market is expected to grow with the CAGR of 20.1% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.
Global prostate cancer diagnostics market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.
The major players dealing in prostate cancer diagnostics market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement into the market. This helped companies to maximize the sales with enhanced product portfolio. For instance, In May 2020, F. Hoffmann-La Roche Ltd officially announced the acquisition of Stratos Genomics. This acquisition leads to the development of DNA-based sequencing for diagnostics use. This enhanced the healthcare diagnosis segment of the company, thus leading to more revenue generation of the company.
FF. Hoffmann-La Roche Ltd is the dominating player in prostate cancer diagnostics market. The other key players existing in the market includes ACON Laboratories, Inc., HUMASIS, Teco Diagnostics, Hologic Inc., Accuquik Test Kits, MDxHealthcare, Abbott, Siemens Healthcare GmbH, OPKO Health Inc., Myraid Genetics, Inc., DiaSorin S.p.A, Beckman Coulter, Inc. (a subsidiary of Danaher), Genomic Health, Inc. (a subsidiary of Exact Sciences Corporation), bioMérieux SA, Metamark Genetics, Inc., Prostatype Genomics, Fujirebio, Proteomedix, Eurolyser Diagnostica GmbH among others domestic.
F. Hoffmann-La Roche Ltd was incorporated in 1896 and is headquartered in Basel, Schweiz. Company is focusing on fitting treatments to patients and providing the right therapy for the group of patient. Company is exclusively concentrating on ophthalmology, diabetes and oncology division. The business segments are pharmaceuticals and diagnostics among which diagnostic is the market focused segment. The product categories provided by the company are anatomic pathology, clinical chemistry & immunochemistry, companion diagnostic, decision support, diabetes care, digital diagnostics, donor screening, hemostasis, lab automation & software solutions, molecular diagnostic, point of care, urinalysis among which anatomic pathology, clinical chemistry & immunochemistry are the market focused categories.
The company has presence across Asia-Pacific, Europe, Middle East Africa, North America and South America and various subsidiaries such as Productos Roche S.A (Colombia), Roche Diabetes Care France SAS (France), Roche Georgia LLC (Georgia), Roche Pharmaceuticals (Israel) Ltd. (Israel), Roche Diagnostics S.p.A. (Italy), Roche Kenya Limited (Kenya), and others.
Siemens Healthcare GmbH
Siemens Healthcare GmbH is headquartered in Forchheim, Germany. The company provides laboratory diagnostics, medical imaging, digital ecosystem, reading solutions among others worldwide. The business segments are imaging, diagnostics & advanced therapies among which diagnostics, imagining are the market focused segments. The product categories of the company are medical imaging, laboratory diagnostics, point of care testing, digital health solutions, services & consulting, clinical specialties, accessories, OEM & electronics & healthcare IT among which laboratory diagnostics, medical imaging are the market focused categories.
The company has wide presence across North America, Europe & Asia and various subsidiaries such as Fast Track Diagnostics Ltd. (Europe), Siemens Healthcare Medical Solutions Limited (Germany), Siemens Healthcare Germany (Germany), among others.
Abbott was founded in 1888 and is headquartered in Florida, U.S. The company focused on helping people lives their healthiest possible lives. The business segments of the company are established pharmaceuticals products, nutritional, diagnostics, medical devices, other among which diagnostics is the market focused category. The product categories are cardiovascular, diabetes care, diagnostics, neuromodulation, nutrition, and medicines among which diagnostics is the market focussed category.
The company has presence in Asia-Pacific, Greater China, Europe, Middle East and Africa, The Americas among which Abbott Administration Inc. (Delaware), Abbott Bioresearch Center, Inc. (Delaware), Abbott Diabetes Care Sales Corporation (Delaware), Abbott Home Infusion Services of New York, Inc. (New York), and Abbott Laboratories Inc. (Delaware) are the market focussed categories.
Global Prostate Cancer Diagnostics Market – Industry Trends and Forecast to 2028
Asia-Pacific Prostate Cancer Diagnostics Market – Industry Trends and Forecast to 2028
Europe Prostate Cancer Diagnostics Market – Industry Trends and Forecast to 2028
Middle East and Africa Prostate Cancer Diagnostics Market – Industry Trends and Forecast to 2028
North America Prostate Cancer Diagnostics Market – Industry Trends and Forecast to 2028